CELH
Celsius Holdings, Inc.
CELH has the edge over LFVN overall, supported by stronger fundamentals and stronger valuation.
LFVN
LifeVantage Corporation
LFVN trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LFVN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Strong |
LFVN's balance sheet is currently strong, and its profitability and cash flow are stable, but its revenue is under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over LFVN in the historical PE scenario, which offers more potential upside but is not a forecast.
LFVN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $1.63 | -68% |
| Forward | 14x | $5.04 | — |
| Fair | 16x | $3.34 | -34% |
| Current | 24x | $5.04 | — |
| Expensive | 30x | $6.36 | +26% |
Historical ranges are pointers, not guarantees.
LFVN's PE is in its expensive range at 24x. On analysts' estimates for next year's earnings, today's price would be 14x, in its fair range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over LFVN on the outlook, with more favorable earnings and revenue expectations.
LFVN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| High |
Analysts expect LFVN's earnings and revenue to decline, with profitability weakening.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
LFVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.37 | +76% |
| Q3 2026 | $0.21 | -73% |
| Q2 2026 | $0.40 | -47% |
| Q1 2026 | $0.46 | -33% |
| Q4 2025 | $0.61 | +8.9% |
| Q3 2025 | $0.78 | +144% |
| Q2 2025 | $0.75 | +226% |
| Q1 2025 | $0.69 | +146% |
| Q4 2024 | $0.56 | +143% |
LFVN has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over LFVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over LFVN on profitability, with a higher operating margin.
LFVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $37.1M | -22% |
| Q2 2026 | $42.4M | -23% |
| Q1 2026 | $43.7M | -25% |
| Q4 2025 | $48.9M | -28% |
| Q3 2025 | $47.6M | +0.7% |
| Q2 2025 | $55.1M | +13% |
| Q1 2025 | $58.4M | +21% |
| Q4 2024 | $67.8M | +31% |
LFVN's revenue has slid since its 2024 peak: $37M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.4% | -5.1 points |
| Q2 2026 | 3.9% | 0 points |
| Q1 2026 | 3.8% | -3.1 points |
| Q4 2025 | 1% | -4.1 points |
| Q3 2025 | 4.8% | -0.7 points |
| Q2 2025 | 3.9% | -2.1 points |
| Q1 2025 | 6.9% | +2.9 points |
| Q4 2024 | 5.1% | +7.5 points |
LFVN's operating margin was −0.4% last quarter, down 5.1 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
LFVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$707K | +$2M |
| Q2 2026 | $3.7M | +347% |
| Q1 2026 | $4M | +110% |
| Q4 2025 | $1.7M | -80% |
| Q3 2025 | -$2.7M | -$1.8M |
| Q2 2025 | $835K | -64% |
| Q1 2025 | $1.9M | -32% |
| Q4 2024 | $8.7M | +617% |
LFVN usually generates cash, though not every quarter: the latest was −$707,000, but it generated $9M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
LFVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.9% | -238K shares |
| 1 year | -3.7% | -482K shares |
| 3 years | -4.9% | -645K shares |
| 5 years | -7.5% | -1M shares |
| Available history | -14% | -2.1M shares |
LFVN has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $460,000 |
| Q1 2026 | $1M |
| Q4 2025 | $1,000 |
| Q3 2025 | $578,000 |
| Q2 2025 | $2M |
| Q1 2025 | — |
| Q4 2024 | — |
LFVN spent $1M buying back its own shares over the past year, down 44% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
LFVN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.1x | Net Cash |
| Q2 2026 | -1.7x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.4x | Net Cash |
| Q4 2024 | -1.5x | Net Cash |
LFVN has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
LFVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 21.4 | Neutral |
LFVN's weekly RSI is 36 (neutral) and its Stochastic is 21 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
LFVN PE vs Consumer Defensive Sector
| Metric | LFVN | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 19x | 23% above |
| PE % | 70 | 18 | 52 pts above |
LFVN has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over LFVN on trend strength, trading above more of its moving averages.
LFVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.79 | 13% below |
| 20 week MA | $6.15 | 18% below |
| 50 week MA | $5.94 | 15% below |
| 100 week MA | $9.78 | 48% below |
| 200 week MA | $8.31 | 39% below |
LFVN is in a downtrend: it's below all five of its weekly moving averages, and 39% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
LFVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.5 | $9.50 | -39% |
| 2021 | $9.50 | $6.55 | -31% |
| 2022 | $6.55 | $3.75 | -43% |
| 2023 | $3.75 | $6.00 | +60% |
| 2024 | $6.00 | $17.9 | +198% |
| 2025 | $17.9 | $6.07 | -66% |
| 2026 YTD | $6.07 | $5.04 | -17% |
LFVN has the edge over CELH on returns for 2026, with the stronger performance.